The global Differentiated Thyroid Cancer Therapeutics Market is expected to reach USD 1.61 Biliion by the end of 2032, with a valuation of USD 0.48 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 14.3%.